Watch Ticker

Galmed Pharmaceuticals Ltd.

Go to Galmed Pharmaceuticals Ltd. Website

$1.63

0.00 (0.00%)

Live

Previous Close

$1.63

Day Range

$0 - $0

Previous Day Range

$1.56 - $1.6499

Market Cap

$8.5 million USD

Day Vol.

Previous Day Vol.

106953

Currency

USD

Primary Exchange

Nasdaq

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PS...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Galmed Pharmaceuticals Launches VCU Collaboration to Tackle Drug Resistance in GI Cancers

Galmed Pharmaceuticals has launched a collaboration with Virginia Commonwealth University to investigate its drug Aramchol's potential in overcoming drug resistance in gastrointestinal cancers, including colorectal and liver cancers.

Related tickers: GLMD.

Read Full Article

Prnewswire - Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor

Galmed Pharmaceuticals has identified novel pharmacodynamic blood markers for its lead compound Aramchol, which provide insights into the drug's potential beyond NASH treatment, including its impact on cardiometabolic and fibrotic conditions.

Related tickers: GLMD.

Read Full Article

Trending Tickers

Please sign in to view